Obinutuzumab

Hepatitis B virus infection: case report

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      Identifying patient details (age and sex) have been obtained through direct communication with the author.

    Reference

    1. Herishanu Y, et al. Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. American Journal of Hematology 95: 604-611, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1002/ajh.25766

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Obinutuzumab. Reactions Weekly 1809, 195 (2020). https://doi.org/10.1007/s40278-020-79979-z

    Download citation